SEM — Select Medical Holdings Corporation stock price, charts and financials

QT57Select Medical Holdings Corporation

Select Medical Holdings Corporation (NYSE: SEM) is a Healthcare company in the Medical - Care Facilities industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
16.51
-0.02-0.12%
SEMQT57Select Medical Holdings Corporation·NYSE
16.51-0.12%
TA
Loading chart...
Screen all →
Snapshot
Index-P/E15.15EPS (ttm)1.09Insider Own17.83%Shs Outstand123.94MPerf Week-0.30%
Market Cap2.05BForward P/E12.35EPS next Y1.34Insider Trans0.00%Shs Float97.34MPerf Month0.06%
Enterprise Value5.01BPEG-EPS next Q-Inst Own-Short Float1.19%Perf Quarter1.35%
Income134.03MP/S0.37EPS this Y11.94%Inst Trans-Short Ratio0.51Perf Half Y11.78%
Sales5.52BP/B1.16EPS next Y9.55%ROA2.21%Short Interest1.15MPerf YTD11.18%
Book/sh-P/C5.89EPS next 5Y5.62%ROE7.83%52W High16.99 -2.83%Perf Year8.12%
Cash/sh-P/FCF17.45EPS past 3/5Y-1.37% -9.37%ROIC4.78%52W Low11.65 41.72%Perf 3Y4.10%
Dividend Est.0.25 (1.51%)EV/EBITDA9.67Sales past 3/5Y-4.87% -0.29%Gross Margin10.65%Volatility0.34% 0.38%Perf 5Y-26.52%
Dividend TTM0.25 (1.51%)EV/Sales0.91EPS Y/Y TTM-34.34%Oper. Margin5.83%ATR (14)0.06Perf 10Y177.01%
Dividend Ex-DateMay 14, 2026Quick Ratio1.15Sales Y/Y TTM6.44%Profit Margin2.42%RSI (14)45.87Recom2.71
Dividend Gr. 3/5Y-2.45% -Current Ratio1.15EPS Q/Q-18.18%SMA20-0.32%Beta0.99Target Price17.75
Payout23.54%Debt/Eq1.70Sales Q/Q5.03%SMA500.03%Rel Volume12.32Prev Close16.53
Employees45,300LT Debt/Eq1.71EarningsJul 30SMA2008.51%Avg Volume2.26MPrice16.51
IPO DateSep 25, 2009Option/ShortYes / YesEPS/Sales Surpr.-21.01% 0.74%Net Debt/EBITDA5.72Volume27,813,219Change-0.12%
Analyst Ratings
DateActionAnalystRatingTarget
May-13-26DowngradeMizuhoOutperformNeutral$17
Mar-04-26DowngradeBenchmarkBuyHold
Mar-03-26DowngradeRBC CapitalOutperformSector Perform
Feb-23-26ReiteratedRBC CapitalOutperform$20$19
Nov-03-25ReiteratedMizuho Securities$17
Oct-08-25ReiteratedRBC CapitalOutperform$40$20
Aug-04-25ReiteratedUBSNeutral$14
Nov-25-24DowngradeBenchmarkBuyHold
May-06-24ReiteratedRBC CapitalOutperform$40
Jun-16-20DowngradeB of A SecuritiesNeutralUnderperform
Latest News
Company

Select Medical Holdings Corporation (SEM) is a U.S.-based healthcare organization that manages a diverse portfolio of specialized medical facilities. The company operates across four primary divisions: critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers. Its Critical Illness Recovery Hospital division focuses on patients with severe and complex medical conditions, such as heart failure, infectious diseases, respiratory failure, renal issues, neurological events, and trauma requiring extended recovery. The Rehabilitation Hospital division delivers therapeutic and rehabilitative care for conditions including brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic challenges, pediatric disabilities, and cancer. The Outpatient Rehabilitation division comprises clinics offering physical, occupational, and speech therapy, alongside specialized programs for work-related injuries, hand therapy, post-concussion recovery, pediatric and cancer rehabilitation, and athletic training. Lastly, the Concentra division provides occupational medicine, consumer health, physical therapy, and wellness services through its occupational health centers and contract services located at employer worksites. As of December 31, 2021, Select Medical's extensive network included 104 critical illness recovery hospitals spanning 28 states, 30 rehabilitation hospitals across 12 states, 1,881 outpatient rehabilitation clinics in 38 states and D.C., 518 occupational health centers in 41 states, and 134 on-site clinics at employer locations. Founded in 1996, the company maintains its headquarters in Mechanicsburg, Pennsylvania.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue5,5215,4535,187
Cost of Goods Sold Incl. D&A4,9334,8244,553
Gross Profit587629634
Selling, General and Administrative Excl. Other161154226
Research and Development
000
Other Operating Expense105141139
Operating Income322335268
Interest Expense117118129
Unusual Expense
Non-Operating Income (Expense)545635
Net Income Before Taxes258273175
Income Taxes555845
Consolidated Net Income134146214
Net Income From Continuing Operations204215130
Net Income134146214
EPS (Recurring)1.091.181.66
EPS (Basic, Before Extraordinaries)1.091.181.66
EPS (Diluted)1.091.181.66
EBITDA518531507
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio15.1512.5811.36
Price To Sales Ratio0.370.340.47
Gross Margin10.6311.5312.22
Operating Margin5.836.145.17
Net Margin2.432.684.13
Shares Outstanding124124129
Market Capitalization2,0471,8412,432
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$19.41$17.25$15.09$12.93$10.77 Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Khanuja Parvinderjit S.DirectorMay 05 '25Buy15.0221,000315,42065,089May 06
CHERNOW DAVID SCEOApr 28 '25Sale18.00225,0004,050,000714,516Apr 29
Breighner Robert G. JRVICE PRESIDENT, COMPLIANCEDec 04 '24Sale19.954,98999,53130,356Dec 06
ORTENZIO ROBERT AEXECUTIVE CHAIRMANNov 26 '24Sale19.553,804,80574,383,9380Nov 29
TAVENNER MARILYN BDirectorNov 26 '24Sale21.0932,000674,88022,000Nov 29
ORTENZIO ROBERT AEXECUTIVE CHAIRMANApr 08 '24Sale29.9050,0001,495,0006,689,668Apr 10
ORTENZIO ROBERT AEXECUTIVE CHAIRMANMar 08 '24Sale28.3050,0001,415,0006,739,668Mar 11
ORTENZIO ROBERT AEXECUTIVE CHAIRMANFeb 08 '24Sale26.0050,0001,300,0006,789,668Feb 09
ORTENZIO ROBERT AEXECUTIVE CHAIRMANJan 08 '24Sale26.63100,0002,663,0006,839,668Jan 09
ORTENZIO ROBERT AEXECUTIVE CHAIRMANDec 14 '23Sale25.00100,0002,500,0006,939,668Dec 14
ORTENZIO ROBERT AEXECUTIVE CHAIRMANSep 08 '23Sale26.8250,0001,341,0007,039,668Sep 11
ORTENZIO ROBERT AEXECUTIVE CHAIRMANAug 08 '23Sale29.5250,0001,476,0007,089,668Aug 09
ORTENZIO ROBERT AEXECUTIVE CHAIRMANJul 10 '23Sale30.3650,0001,518,0006,889,668Jul 11
ORTENZIO ROBERT AEXECUTIVE CHAIRMANJun 29 '23Sale32.00100,0003,200,0001,279,000Jun 30
ORTENZIO ROBERT AEXECUTIVE CHAIRMANJun 21 '23Sale30.0033,9671,019,0101,379,000Jun 22
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.